Influenza Vaccine Effectiveness Against Outpatient Acute Respiratory Illness With Laboratory-confirmed Influenza, United States, 2024–2025 Season
Clinical Infectious Diseases · 14.07.2026
DOI: 10.1093/cid/ciag437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 14.07.2026. Verfasst von Jessie R Chung und 26 weiteren Autor:innen. Beteiligte Einrichtung: Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCIRD CDC HHS, NCATS NIH HHS, Intramural CDC HHS.
Abstract (Originalsprache)
Background
Influenza A(H1N1)pdm09 and A(H3N2) viruses predominated during the 2024–2025 US influenza season. We estimated influenza vaccine effectiveness (VE) in the United States against mild-to-moderate outpatient influenza illness by influenza type and subtype in the 2024–2025 season.
Methods
We enrolled outpatients aged ≥8 months with acute respiratory illness symptoms including cough from outpatient health clinics, urgent care clinics, and emergency departments in 7 states. Upper respiratory specimens were tested for influenza type/subtype by reverse-transcriptase polymerase chain reaction. Influenza VE was estimated with a test-negative design comparing odds of testing positive for influenza among vaccinated versus unvaccinated participants controlling for age, study site, underlying health status, and month of illness onset. We also estimated VE of current season vaccination among adults stratified by prior season vaccination status.
Results
Among 6793 enrolled patients, 2016 (30%) tested positive for influenza including 961 A(H3N2), 770 A(H1N1)pdm09, and 183 B/Victoria. Overall VE against any influenza illness was 33% (95% confidence interval [CI]: 24 to 41): 27% (95% CI: 14 to 39) against influenza A(H3N2), 37% (95% CI: 24 to 48) against A(H1N1)pdm09, and 40% (95% CI: 12 to 59) against B/Victoria. We did not detect statistically significant interaction between current and prior season vaccination.
Conclusions
Influenza vaccination during the 2024–2025 season protected against circulating influenza viruses, reducing the risk of outpatient medically attended influenza overall by approximately one-third among people who were vaccinated.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Influenza Division, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
- Washington University School of Medicine in St. Louis, Department of Emergency Medicine, St. Louis, MO, USA.
- Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
- Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.
- University of Washington, Department of Epidemiology, Seattle, WA, USA.
- University of Michigan School of Public Health, Ann Arbor, MI, USA.
ORCID-Profile: Jessie R Chung, Ashley M Price, Karen J Wernli, Magali Sanchez, Ivana A Vaughn, Vel Murugan, Elie A Saade, Kiran Faryar, Manjusha Gaglani, Richard K Zimmerman, Louise H Taylor, Rebecca Kondor, Emma K Noble, Kelsey M Sumner, Sascha R Ellington
Förderung
- NCIRD CDC HHS
- NCATS NIH HHS
- Intramural CDC HHS
Zitieren
APA
Chung, J. R., Price, A. M., House, S. L., Mills, J., Wernli, K. J., Sanchez, M., Martin, E. T., Vaughn, I. A., Murugan, V., Kramer, J., Saade, E. A., Faryar, K., Gaglani, M., Raiyani, C., Zimmerman, R. K., Taylor, L. H., Williams, O. L., Walter, E. B., DaSilva, J., …, & US Flu VE Network Investigators (2026). Influenza Vaccine Effectiveness Against Outpatient Acute Respiratory Illness With Laboratory-confirmed Influenza, United States, 2024–2025 Season. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag437
Vancouver
Chung JR, Price AM, House SL, Mills J, Wernli KJ, Sanchez M, et al. Influenza Vaccine Effectiveness Against Outpatient Acute Respiratory Illness With Laboratory-confirmed Influenza, United States, 2024–2025 Season. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag437
BibTeX
@article{Chung2026,
author = {Chung, Jessie R and Price, Ashley M and House, Stacey L and Mills, Jamie and Wernli, Karen J and Sanchez, Magali and Martin, Emily T and Vaughn, Ivana A and Murugan, Vel and Kramer, Joanna and Saade, Elie A and Faryar, Kiran and Gaglani, Manjusha and Raiyani, Chandni and Zimmerman, Richard K and Taylor, Louise H and Williams, Olivia L and Walter, Emmanuel B and DaSilva, Juliana and Kirby, Marie K and Levine, Min Z and Kondor, Rebecca and Noble, Emma K and Sumner, Kelsey M and Ellington, Sascha R and Flannery, Brendan and US Flu VE Network Investigators, US Flu VE Network Investigators},
title = {Influenza Vaccine Effectiveness Against Outpatient Acute Respiratory Illness With Laboratory-confirmed Influenza, United States, 2024–2025 Season},
journal = {Clinical Infectious Diseases},
year = {2026},
doi = {10.1093/cid/ciag437}
}
EUVIMED